Biblioteca
Alertas Bibliográficas
DIABETES
Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.
Shaw JL, Bannuru RR, Beach L et al.
Diabetes Care. 2024.
https://doi.org/10.2337/dci24-0073
De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D).
Rodriguez P, Breslaw N, Xiao H et al.
Diabetes Obes Metab. 2024.
https://doi.org/10.1111/dom.16057
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
Tacke F, Horn P, Wai-Sun Wong V et al.
J Hepatol. 2024 Sep;81(3):492-542.
https://doi.org/10.1016/j.jhep.2024.04.031
High frequency of severe hyperglycemia observed during intensive hematological care: a prospective study using continuous glucose monitoring.
Tienstra M, de Boer JW, van Doesum JA et al.
Endocr Pract. 2024.
https://doi.org/10.1016/j.eprac.2024.09.013
Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis.
Lewis SJ, Williams CL, Mortimer GL et al.
Diabet Med. 2024.
https://doi.org/doi:10.1111/dme.15394
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.
Drucker DJ.
Diabetes Care. 2024 Jun 6:dci240003.
doi:10.2337/dci24-0003
ENDOCRINOLOGÍA
Genomic Considerations in the Treatment of Thyroid Carcinoma.
Hattum CJ, Elsey RJ, Meissner T, Spanos WC.
JCO Oncol Pract. 2024;20(7):873-875.
https://www.doi.org/10.1200/OP.24.00198
Polycystic ovary syndrome
Stener-Victorin E, Teede H, Norman RJ, et al. P
Nat Rev Dis Primers. 2024 Apr 18;10(1):27.
https://www.doi.org/10.1038/s41572-024-00511-3
Graves disease: latest understanding of pathogenesis and treatment options. Nat Rev Endocrinol.
Lanzolla G, Marinò M, Menconi F.
Published online July 22, 2024.
doi:10.1038/s41574-024-01016-5
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed MediatorsMulders MCF, de Herder WW, Hofland J.Endocr Rev. 2024 May 7;45(3):351-360.
doi: 10.1210/endrev/bnad035
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks.Mullen N, Curneen J, Donlon PT, et al.
Endocr Rev. 2024 Jan 4;45(1):125-170.
doi: 10.1210/endrev/bnad026
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia
Kyriakie Sarafoglou, Mimi S Kim, Maya Lodish, et al.
N Engl J Med. 2024 Jun 2.
doi: 10.1056/NEJMoa2404655
PEDIATRÍA
The current state of long-acting growth hormone preparations for growth hormone therapy.
Yuen KCJ, Miller BS, Biller BMK.
Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):267-273.
http://doi.org/10.1097/MED.0000000000000416
Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.
Hoffmann A, Adelmann S, Lohle K, Claviez A, Müller HL.
Eur J Pediatr. 2018 Jan;177(1):125-132.
http://doi.org/10.1007/s00431-017-3042-5
Epub 2017 Nov 22.
Heterozygous aggrecan variants are associated with short stature and brachydactyly: Description of 16 probands and a review of the literature.
Sentchordi-Montané L, Aza-Carmona M, Benito-Sanz S, Barreda-Bonis AC, Sánchez-Garre C, Prieto-Matos P et al.
Clin Endocrinol (Oxf). 2018 Jun;88(6):820-829.
http://doi.org/10.1111/cen.13581
Epub 2018 Mar 24.
New developments in the genetic diagnosis of short stature.
Jee YH, Baron J, Nilsson O.
Curr Opin Pediatr. 2018 May 18.
http://doi.org/10.1097/MOP.0000000000000653
[Epub ahead of print]
Growth Outcomes After GH Therapy of Patients Given Long-Term Corticosteroids for Juvenile Idiopathic Arthritis.
David H, Aupiais C, Louveau B, Quartier P, Jacqz-Aigrain E, Carel JC, Simon D.
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4578-4587.
doi: http://doi.org/10.1210/jc.2017-01455
IHH Gene Mutations Causing Short Stature With Nonspecific Skeletal Abnormalities and Response to Growth Hormone Therapy
Vasques GA, Funari MFA, Ferreira FM, Aza-Carmona M, Sentchordi-Montané L, Barraza-García J et al.
J Clin Endocrinol Metab. 2018 Feb 1;103(2):604-614.
doi: http://doi.org/10.1210/jc.2017-02026
CIENCIAS BÁSICAS
Mechanisms of Insulin Action and Insulin Resistance.
Petersen MC, Shulman GI.
Physiol Rev. 2018 Oct 1;98(4):2133-2223.
http://doi.org/10.1152/physrev.00063.2017
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Buzzetti E, Pinzani M, Tsochatzis EA.
Metabolism. 2016 Aug;65(8):1038-48.
http://doi.org/10.1016/j.metabol.2015.12.012
DNA methylation in the pathogenesis of type 2 diabetes in humans.
Davegårdh C, García-Calzón S, Bacos K, Ling C.
Mol Metab. 2018 Feb 7. pii: S2212-8778(17)31102-X.
https://doi.org/10.1016/j.molmet.2018.01.022
Effect of Iodothyronines on Thermogenesis: Focus on Brown Adipose Tissue.
Cioffi F, Gentile A, Silvestri E, Goglia F, Lombardi A.
Front Endocrinol (Lausanne). 2018 May 23;9:254.
http://doi.org/10.3389/fendo.2018.00254
eCollection 2018. Review. PubMed PMID: 29875734; PubMed Central PMCID: PMC5974034.
MicroRNA-204-5p regulates 3T3-L1 preadipocyte proliferation, apoptosis and differentiation.
Du J, Zhang P, Gan M, Zhao X, Xu Y, Li Q et al.
Gene. 2018 Aug 20;668:1-7.
http://doi.org/10.1016/j.gene.2018.05.036
Epub 2018 May 18. PubMed PMID: 29775748.
The Circadian Clock in White and Brown Adipose Tissue: Mechanistic, Endocrine, and Clinical Aspects.
Froy O, Garaulet M.
Endocr Rev. 2018 Jun1;39(3):261-273.
http://doi.org/10.1210/er.2017-00193
PubMed PMID: 29490014